메뉴 건너뛰기




Volumn 22, Issue 6, 2015, Pages 1901-1907

Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; CHILD; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER NEOPLASMS; LIVER RESECTION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MONTE CARLO METHOD; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TUMOR INVASION; VERY ELDERLY; YOUNG ADULT;

EID: 84939992929     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-4099-2     Document Type: Article
Times cited : (36)

References (25)
  • 1
    • 84855314307 scopus 로고    scopus 로고
    • Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
    • PID: 2204776
    • Clavien PA, Lesurtel M, Bossuyt PMM, Gores GJ, Langer B, Perrier A. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol. 2012;13:e11–22.
    • (2012) Lancet Oncol. , vol.13 , pp. 11-22
    • Clavien, P.A.1    Lesurtel, M.2    Bossuyt, P.M.M.3    Gores, G.J.4    Langer, B.5    Perrier, A.6
  • 2
    • 79951683605 scopus 로고    scopus 로고
    • Hepatocellular carcinoma: current management and perspectives for the future
    • PID: 2126331
    • Rahbari NN, Mehrabi A, Mollberg NM, et al. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg. 2011;253:453–69.
    • (2011) Ann Surg. , vol.253 , pp. 453-469
    • Rahbari, N.N.1    Mehrabi, A.2    Mollberg, N.M.3
  • 3
    • 80052301091 scopus 로고    scopus 로고
    • Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?
    • PID: 2186595
    • Koniaris LG, Levi DM, Pedroso FE, et al. Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg. 2011;254:527–37.
    • (2011) Ann Surg. , vol.254 , pp. 527-537
    • Koniaris, L.G.1    Levi, D.M.2    Pedroso, F.E.3
  • 4
    • 58749114739 scopus 로고    scopus 로고
    • Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables
    • PID: 1915332
    • Cescon M, Cucchetti A, Grazi GL, et al. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables. Arch Surg. 2009;144:57–63.
    • (2009) Arch Surg. , vol.144 , pp. 57-63
    • Cescon, M.1    Cucchetti, A.2    Grazi, G.L.3
  • 5
    • 77955256950 scopus 로고    scopus 로고
    • The survival benefit of liver transplantation in hepatocellular carcinoma patients
    • PID: 2038143
    • Cillo U, Vitale A, Volk ML, et al. The survival benefit of liver transplantation in hepatocellular carcinoma patients. Dig Liver Dis. 2010;42:642–9.
    • (2010) Dig Liver Dis. , vol.42 , pp. 642-649
    • Cillo, U.1    Vitale, A.2    Volk, M.L.3
  • 6
    • 84858708400 scopus 로고    scopus 로고
    • National trends in surgical procedures for hepatocellular carcinoma: 1998–2008
    • PID: 2200938
    • Nathan H, Segev DL, Mayo SC, et al. National trends in surgical procedures for hepatocellular carcinoma: 1998–2008. Cancer. 2012;118:1838–44.
    • (2012) Cancer. , vol.118 , pp. 1838-1844
    • Nathan, H.1    Segev, D.L.2    Mayo, S.C.3
  • 7
    • 79952231921 scopus 로고    scopus 로고
    • American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update
    • PID: 2137466
    • Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–2.
    • (2011) Hepatology. , vol.53 , pp. 1020-1022
    • Bruix, J.1    Sherman, M.2
  • 8
    • 79959542936 scopus 로고    scopus 로고
    • Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study
    • PID: 2168421
    • Vitale A, Ramirez Morales R, Zanus G, et al. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. Lancet Oncol. 2011;12:654–62.
    • (2011) Lancet Oncol. , vol.12 , pp. 654-662
    • Vitale, A.1    Morales, R.R.2    Zanus, G.3
  • 9
    • 63449088149 scopus 로고    scopus 로고
    • Survival benefit–based deceased-donor liver allocation
    • COI: 1:STN:280:DC%2BD1M3lsFWgug%3D%3D, PID: 1934141
    • Schaubel DE, Guidinger MK, Biggins SW, et al. Survival benefit–based deceased-donor liver allocation. Am J Transplant. 2009;9:970–81.
    • (2009) Am J Transplant. , vol.9 , pp. 970-981
    • Schaubel, D.E.1    Guidinger, M.K.2    Biggins, S.W.3
  • 10
    • 57749191711 scopus 로고    scopus 로고
    • Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
    • PID: 1905875
    • Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10:35–43.
    • (2009) Lancet Oncol. , vol.10 , pp. 35-43
    • Mazzaferro, V.1    Llovet, J.M.2    Miceli, R.3
  • 11
    • 84155178981 scopus 로고    scopus 로고
    • Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis
    • PID: 2193238
    • Fuks D, Dokmak S, Paradis V, Diouf M, Durand F, Belghiti J. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology. 2012;55:132–40.
    • (2012) Hepatology. , vol.55 , pp. 132-140
    • Fuks, D.1    Dokmak, S.2    Paradis, V.3    Diouf, M.4    Durand, F.5    Belghiti, J.6
  • 12
    • 28844490547 scopus 로고    scopus 로고
    • Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies
    • PID: 1629801
    • D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–31.
    • (2006) J Hepatol. , vol.44 , pp. 217-231
    • D’Amico, G.1    Garcia-Tsao, G.2    Pagliaro, L.3
  • 13
    • 84858658381 scopus 로고    scopus 로고
    • EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–43
    • EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–43.
  • 14
    • 84873392306 scopus 로고    scopus 로고
    • Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions
    • COI: 1:CAS:528:DC%2BC3sXktFGqsQ%3D%3D, PID: 2339753
    • Bolondi L, Burroughs A, Dufour JF, et al. Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis. 2012;32:348–59.
    • (2012) Semin Liver Dis. , vol.32 , pp. 348-359
    • Bolondi, L.1    Burroughs, A.2    Dufour, J.F.3
  • 15
    • 0020445539 scopus 로고
    • A convenient approximation of life expectancy (the “DEALE”). I. Validation of the method
    • COI: 1:STN:280:DyaL3s%2FntFyluw%3D%3D, PID: 714888
    • Beck JR, Kassirer JP, Pauker SG. A convenient approximation of life expectancy (the “DEALE”). I. Validation of the method. Am J Med. 1982;73:883–8.
    • (1982) Am J Med. , vol.73 , pp. 883-888
    • Beck, J.R.1    Kassirer, J.P.2    Pauker, S.G.3
  • 16
    • 35148835537 scopus 로고    scopus 로고
    • Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA
    • PID: 1717333
    • O’Hagan A, Stevenson M, Madan J. Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA. Health Econ. 2007;16:1009–23.
    • (2007) Health Econ. , vol.16 , pp. 1009-1023
    • O’Hagan, A.1    Stevenson, M.2    Madan, J.3
  • 17
    • 0025681857 scopus 로고
    • Indexes and boundaries for “quantitative significance” in statistical decisions
    • COI: 1:STN:280:DyaK3M%2FntlWmsQ%3D%3D, PID: 225476
    • Burnand B, Kernan WN, Feinstein AR. Indexes and boundaries for “quantitative significance” in statistical decisions. J Clin Epidemiol. 1990;43:1273–84.
    • (1990) J Clin Epidemiol. , vol.43 , pp. 1273-1284
    • Burnand, B.1    Kernan, W.N.2    Feinstein, A.R.3
  • 18
    • 34547679626 scopus 로고    scopus 로고
    • Boosted regression trees with errors in variables
    • PID: 1768851
    • Sexton J, Laake P. Boosted regression trees with errors in variables. Biometrics. 2007;63:586–92.
    • (2007) Biometrics. , vol.63 , pp. 586-592
    • Sexton, J.1    Laake, P.2
  • 19
    • 84901231479 scopus 로고    scopus 로고
    • Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on “number of patients needed to transplant” as measure of transplant benefit
    • Vitale A, Cucchetti A, Qiao GL, et al. Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on “number of patients needed to transplant” as measure of transplant benefit. J Hepatol. 2014;60(6):1165-71
    • (2014) J Hepatol , vol.60 , Issue.6 , pp. 1165-1171
    • Vitale, A.1    Cucchetti, A.2    Qiao, G.L.3
  • 20
    • 84921026730 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria
    • Lim KC, Wang VW, Siddiqui FJ, et al. Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria. Hepatology. 2014 doi:10.1002/hep.27135
    • (2014) Hepatology
    • Lim, K.C.1    Wang, V.W.2    Siddiqui, F.J.3
  • 21
    • 84857649294 scopus 로고    scopus 로고
    • Are patients with Child’s A cirrhosis and hepatocellular carcinoma appropriate candidates for liver transplantation?
    • COI: 1:STN:280:DC%2BC383mvFajtg%3D%3D, PID: 2212343
    • Berry K, Ioannou GN. Are patients with Child’s A cirrhosis and hepatocellular carcinoma appropriate candidates for liver transplantation? Am J Transplant. 2012;12:706–17.
    • (2012) Am J Transplant. , vol.12 , pp. 706-717
    • Berry, K.1    Ioannou, G.N.2
  • 22
    • 70350020415 scopus 로고    scopus 로고
    • Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score
    • PID: 1975685
    • Hsu KY, Chau GY, Lui WY, Tsay SH, King KL, Wu CW. Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score. World J Surg. 2009;33:2412–9.
    • (2009) World J Surg. , vol.33 , pp. 2412-2419
    • Hsu, K.Y.1    Chau, G.Y.2    Lui, W.Y.3    Tsay, S.H.4    King, K.L.5    Wu, C.W.6
  • 23
    • 71149083124 scopus 로고    scopus 로고
    • Perioperative risk assessment for hepatocellular carcinoma by using the MELD score
    • PID: 1966246
    • Delis SG, Bakoyiannis A, Dervenis C, Tassopoulos N. Perioperative risk assessment for hepatocellular carcinoma by using the MELD score. J Gastrointest Surg. 2009;13:2268–75.
    • (2009) J Gastrointest Surg. , vol.13 , pp. 2268-2275
    • Delis, S.G.1    Bakoyiannis, A.2    Dervenis, C.3    Tassopoulos, N.4
  • 24
    • 25144483939 scopus 로고    scopus 로고
    • Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma
    • PID: 1612395
    • Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11:1086–92.
    • (2005) Liver Transpl. , vol.11 , pp. 1086-1092
    • Pawlik, T.M.1    Delman, K.A.2    Vauthey, J.N.3
  • 25
    • 44649111962 scopus 로고    scopus 로고
    • Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma
    • PID: 1854987
    • Ishizawa TI, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134:1908–16.
    • (2008) Gastroenterology. , vol.134 , pp. 1908-1916
    • Ishizawa, T.I.1    Hasegawa, K.2    Aoki, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.